Our Product
We will quickly deliver news for a happy companionship with your pet.
UDCA Tab (L: 400 mg)
Target Animals
Dogs, Cats
Benefits / Effects
Indications
Prevention and treatment of acute and chronic hepatitis, hepatomegaly, fatty liver, and jaundice. Also indicated for improvement of bile secretion disorders, hepatic intoxication, and liver dysfunction caused by hepatic parasites.
Active Ingredient
Ursodeoxycholic Acid
Content (mg)
200 mg
Flavor
Features

Key information

Active Ingredient : Ursodeoxycholic acid, UDCA

Formulation Type : Tablet

specifications : UDCA 200mg x 500T

Efficacy : Treatment for indications and Improvement of liver function

Indications : Prevention and treatment of acute hepatitis, chronic hepatitis, liver swelling, fatty liver, and jaundice. Improvement of bile secretion failure, liver poisoning, liver dysfunctions caused by liver parasites, etc.

Dosage : Oral administration of 10-15 mg of ursodeoxycholic acid (UDCA) per kg of body weight once or twice a day


99% High-Purity UDCA
Formulated with 99% high-purity UDCA that produced at Daewoong Bio’s c GMP facility


The First UDCA in Tablet form in Korea
- Chewable Tablets
- Enhanced Palatability and Convenience of Administration


Liver Function Improvement
Promotion of Metabolism, Clearance of Waste and Toxins, and Facilitation of Bile Excretion *


[Ref] 1) Clinical features and outcomes in 38 dogs with cholelithiasis receiving conservative or surgical management. J Vet Intern Med. 2021 Nov-Dec; 35(6): 2730–2742